11.56 USD
-0.04
0.34%
At close Jan 17, 4:00 PM EST
After hours
11.76
+0.20
1.73%
1 day
-0.34%
5 days
-5.94%
1 month
-4.70%
3 months
-20.06%
6 months
-34.21%
Year to date
-3.18%
1 year
-31.52%
5 years
-67.56%
10 years
-35.74%
 

About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Employees: 1,315

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

288% more call options, than puts

Call options by funds: $3.37M | Put options by funds: $868K

9% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 116

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

2% less capital invested

Capital invested by funds: $4.07B [Q2] → $4B (-$63.9M) [Q3]

3% less funds holding

Funds holding: 345 [Q2] → 333 (-12) [Q3]

10.13% less ownership

Funds ownership: 120.16% [Q2] → 110.03% (-10.13%) [Q3]

16% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 32

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$15
30%
upside
Avg. target
$15
30%
upside
High target
$15
30%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Guggenheim
Subbu Nambi
50% 1-year accuracy
5 / 10 met price target
30%upside
$15
Buy
Initiated
19 Dec 2024

Financial journalist opinion

Based on 10 articles about NEOG published over the past 30 days

Positive
Zacks Investment Research
3 days ago
NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit
Neogen launches the new Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96) to deliver consistency and sensitivity with an easy-to-use workflow that saves time and resources.
NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit
Neutral
PRNewsWire
4 days ago
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
LANSING, Mich. , Jan. 16, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96).
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
Negative
Zacks Investment Research
5 days ago
NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls
NEOG's Food Safety business witnesses a slight year-over-year decrease in revenues for the second quarter of fiscal 2025.
NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls
Neutral
Seeking Alpha
1 week ago
Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript
Neogen Corporation (NASDAQ:NEOG) Q2 2025 Earnings Conference Call January 10, 2024 8:00 AM ET.
Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
Neogen (NEOG) Q2 Earnings Match Estimates
Neogen (NEOG) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago.
Neogen (NEOG) Q2 Earnings Match Estimates
Neutral
PRNewsWire
1 week ago
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
Revenue of $231.3 million. Net loss of $456.3 million due to non-cash goodwill impairment; $(2.10) per diluted share.
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
Neutral
PRNewsWire
1 week ago
Neogen® To Participate in Upcoming Investor Conferences
LANSING, Mich. , Jan. 7, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in two upcoming investor conferences.
Neogen® To Participate in Upcoming Investor Conferences
Positive
Zacks Investment Research
2 weeks ago
Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Neogen (NEOG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2024.
Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS
Negative
Zacks Investment Research
2 weeks ago
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
NEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products.
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Neutral
PRNewsWire
2 weeks ago
Neogen® Announces Change to Second-Quarter Earnings Release Date
LANSING, Mich. , Jan. 2, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that, due to U.S. equity markets being closed in observance of the National Day of Mourning for former U.S. President Jimmy Carter, it will now issue its second-quarter earnings release before the opening of the market on Friday, January 10, 2025.
Neogen® Announces Change to Second-Quarter Earnings Release Date
Charts implemented using Lightweight Charts™